Remicade
Ixifi, a Biosimilar for RA, Receives Approval
FDA approves another biosimilar for Remicade. Ixifi has all of the same indications.
DECEMBER 14, 2017

FDA Approves Second Biosimilar of Remicade
Renlexis, a TNF blocker, will be indicated for the treatment of adult and pediatric Crohn’s disease, adult ...
APRIL 24, 2017

FDA Approves Inflectra, Biosimilar to Remicade
Inflectra is the second U.S. biosimilar approved and the first monoclonal antibody.
APRIL 6, 2016

FDA Panel Recommends Approval for Second Biosimilar
Based on the biological similarity o the innovator product, the panel endorsed its use for the all the indications ...
FEBRUARY 10, 2016

Load more